NEW YORK, April 27, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Express Scripts Holding Company ("Express Scripts" or the "Company") (NasdaqGS: ESRX). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/esrx.
The investigation concerns whether Express Scripts and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On April 24, 2017, Express Scripts revealed that it is losing its biggest customer, Anthem Inc. Anthem said it will not renew its contract when it expires in 2019 because Express Scripts overcharged it by billions of dollars.
If you are aware of any facts relating to this investigation, or purchased shares of Express Scripts, you can assist this investigation by visiting the firm's site: www.bgandg.com/esrx. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
SOURCE Bronstein, Gewirtz & Grossman, LLC